BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 15017107)

  • 1. The multifocal pattern electroretinogram in chloroquine retinopathy.
    Neubauer AS; Stiefelmeyer S; Berninger T; Arden GB; Rudolph G
    Ophthalmic Res; 2004; 36(2):106-13. PubMed ID: 15017107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of color vision defects in chloroquine retinopathy.
    Vu BL; Easterbrook M; Hovis JK
    Ophthalmology; 1999 Sep; 106(9):1799-803; discussion 1804. PubMed ID: 10485553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinal toxicity of high-dose hydroxychloroquine in patients with chronic graft-versus-host disease.
    Navajas EV; Krema H; Hammoudi DS; Lipton JH; Simpson ER; Boyd S; Easterbrook M
    Can J Ophthalmol; 2015 Dec; 50(6):442-50. PubMed ID: 26651304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel method for screening the multifocal electroretonogram in patients using hydroxychloroquine.
    Chang WH; Katz BJ; Warner JE; Vitale AT; Creel D; Digre KB
    Retina; 2008; 28(10):1478-86. PubMed ID: 18997610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multifocal electroretinographic evaluation of long-term hydroxychloroquine users.
    Maturi RK; Yu M; Weleber RG
    Arch Ophthalmol; 2004 Jul; 122(7):973-81. PubMed ID: 15249360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinal toxicity associated with hydroxychloroquine and chloroquine: risk factors, screening, and progression despite cessation of therapy.
    Michaelides M; Stover NB; Francis PJ; Weleber RG
    Arch Ophthalmol; 2011 Jan; 129(1):30-9. PubMed ID: 21220626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The ERG contribution in early diagnosis of chloroquine and hydroxychloroquine maculopathy].
    Karkanová M; Matusková V; Vlková E; Dosková H; Uhmannová R
    Cesk Slov Oftalmol; 2010 Apr; 66(2):62-6. PubMed ID: 20925239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The sensitivity of Amsler grid testing in early chloroquine retinopathy.
    Easterbrook M
    Trans Ophthalmol Soc U K (1962); 1985; 104 ( Pt 2)():204-7. PubMed ID: 3857780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multifocal ERG in chloroquine retinopathy: regional variance of retinal dysfunction.
    Kellner U; Kraus H; Foerster MH
    Graefes Arch Clin Exp Ophthalmol; 2000 Jan; 238(1):94-7. PubMed ID: 10664060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Retinal pigment epithelium--the point about safety of antimalarial agents].
    Vanheesbeke A
    Bull Soc Belge Ophtalmol; 2007; (304):47-58. PubMed ID: 17718227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of different screening methods for chloroquine/hydroxychloroquine retinopathy: multifocal electroretinography, color vision, perimetry, ophthalmoscopy, and fluorescein angiography.
    Missner S; Kellner U
    Graefes Arch Clin Exp Ophthalmol; 2012 Mar; 250(3):319-25. PubMed ID: 22215255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accuracy of Amsler grid in screening for chloroquine retinopathy.
    Suansilpong A; Uaratanawong S
    J Med Assoc Thai; 2010 Apr; 93(4):462-6. PubMed ID: 20462090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The multifocal pattern electroretinogram (mfPERG) and cone-isolating stimuli.
    Langrová H; Jägle H; Zrenner E; Kurtenbach A
    Vis Neurosci; 2007; 24(6):805-16. PubMed ID: 18093368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fundus autofluorescence and mfERG for early detection of retinal alterations in patients using chloroquine/hydroxychloroquine.
    Kellner U; Renner AB; Tillack H
    Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3531-8. PubMed ID: 16877425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blue-yellow perimetry can be an early detector of hydroxychloroquine and chloroquine retinopathy.
    Razeghinejad MR; Torkaman F; Amini H
    Med Hypotheses; 2005; 65(3):629-30. PubMed ID: 15949899
    [No Abstract]   [Full Text] [Related]  

  • 16. Disparity between visual fields and optical coherence tomography in hydroxychloroquine retinopathy.
    Marmor MF; Melles RB
    Ophthalmology; 2014 Jun; 121(6):1257-62. PubMed ID: 24439759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Severe chloroquine- and hydroxychloroquine-induced retinopathy].
    Ingster-Moati I; Bui Quoc E; Crochet M; Orssaud C; Dufier JL; Roche O
    J Fr Ophtalmol; 2006 Jun; 29(6):642-50. PubMed ID: 16885894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chloroquine and hydroxychloroquine retinopathy: how to follow affected patients.
    Ruiz RS; Saatci OA
    Ann Ophthalmol; 1991 Aug; 23(8):290-1. PubMed ID: 1952637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ocular damage in chloroquine therapy.
    Nylander U
    Acta Ophthalmol (Copenh); 1967; ():Suppl 92:1-71. PubMed ID: 4866642
    [No Abstract]   [Full Text] [Related]  

  • 20. Quantitative assessment of the 103-hexagon multifocal electroretinogram in detection of hydroxychloroquine retinal toxicity.
    Adam MK; Covert DJ; Stepien KE; Han DP
    Br J Ophthalmol; 2012 May; 96(5):723-9. PubMed ID: 22328813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.